Table 1.
Clinical and demographic data of the 11 participants in the CI group.
| Participant (gender) | Age at project start (years) | Etiology of deafness | Side of first implant | Contralateral use of HA | CI 1 experience (years) | CI 2 experience (years) | Use of sign-languagee | Use of lip-readinge | Ability to speak on the phone |
|---|---|---|---|---|---|---|---|---|---|
| CI GROUP | |||||||||
| CI 1 (F) | 17.8 | aCong. non-spec. | L | 10.1 | 5.9 | 4 | 5 | X | |
| CI 2 (F) | 15.5 | bPendred | R | X | 4.1 | 1 | 2 | X | |
| CI 3 (F) | 16.5 | Unknown | L | 11.1 | 5.6 | 5 | 5 | X | |
| CI 4 (M) | 16.6 | cCMV | L | X | 3.0 | 1 | 2 | X | |
| CI 5 (M) | 18.8 | Cong. non-spec. | R | 9.9 | 5.7 | 4 | 2 | ||
| CI 6 (M) | 17.3 | Cong. non-spec. | R | 11.4 | 6.1 | 3 | 4 | X | |
| CI 7 (F) | 16.2 | Pendred | R | 11.8 | 5.0 | 3 | 3 | ||
| CI 8 (M) | 16.6 | Meningitis | L | 13.4 | 6.0 | 3 | 2 | X | |
| CI 9 (F) | 17.4 | dHer. non-spec. | R | 15.7 | 6.2 | 4 | 3 | X | |
| CI 10 (M) | 16.7 | CMV | L | 1.8 | 0.1 | 3 | 5 | X | |
| CI 11 (F) | 17.6 | Cong. non-spec. | L | 12.0 | 6.1 | 5 | 5 | X | |
| Mean | 17.0 | 9.5 | 5.2 | 3.3 | 3.5 | ||||
| Range | (15.6–18.8) | (1.8–15.2) | (0.1–6.2) | ||||||
aNon-specified congenital hearing loss.
bPendred Syndrome.
cCytomegalovirus.
dNon-specified hereditary hearing loss.
eIndicated on a scale where 5 is “everyday” and 1 is “never.”